HIV感染者の長期的な結核治療の可能性:費用対効果のベンチマーク
Amy Zheng1, Eden Pletner2, Keren Middelkoop3,4
1Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University Irving Medical Center, New York, NY, United States.
Annals of the American Thoracic Society
|February 21, 2026
まとめ
新しい長効性注射結核治療は,南アフリカでの治療結果を改善する見通しを示しています. このアプローチは費用対効果が高く,特に標準的な経口療法から患者の離脱率が高い場合です.
科学分野:
- 公衆衛生は公衆衛生である.
- 感染症 感染症は感染症です.
- 健康経済学 医療経済学
背景:
- 南アフリカにおける結核 (TB) 治療の成果は,高いHIV共感染率と患者の退去によって妨げられています.
- 長期効力を有する結核薬は,潜在的な利点を提供しますが,費用対効果の慎重な評価が必要です.
研究 の 目的:
- 南アフリカにおけるHIV感染者に対する標準的な経口治療と比較して,長期間有効な結核治療が臨床的に有益で費用対効果の高いシナリオを決定する.
- 長期にわたるTB治療の費用対効果に対する有効性,費用,および患者の離脱の影響を分析する.
主な方法:
- 顕微シミュレーションモデルでは,標準治療の6ヶ月の経口結核治療 (SOC) と長効 (LA) 治療 (2ヶ月の経口療法+1回注射) を比較した.
- モデルのパラメータには,有効性,毎月の退治率,TB再発率,および治療費総額が含まれていました.
- 費用対効果は,インクリメンタル費用対効果比 (ICER) <1年間の寿命節約 (YLS) につき3,000米ドル以下と定義されました.
主要な成果:
- LA戦略は,SOCと比較して,あらゆる原因による死亡率 (11.4%対11.6%) と脱退率 (12.9%対20.9%) の低下を示した.
- LAは,ベースケースシミュレーションにおいて24ヶ月 (ICER $2,230/YLS) と生涯 (ICER $520/YLS) の両方で費用対効果的であった.
- LAは,ライフタイム・ホライゾンにおける片道感受性分析において,評価されたすべてのパラメータ範囲において,費用対効果が維持された.
結論:
- 長期にわたる注射性結核治療は,特定の条件下で,従来の経口療法と比較して費用対効果が高くなります.
- 費用対効果は,高い効果と合理的なコストで達成可能である,特に標準の経口結核治療からの脱却が高い場合.
関連する概念動画
01:28Pulmonary Tuberculosis V
663
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
663
01:26Pulmonary Tuberculosis IV
560
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
560
01:29Pulmonary Tuberculosis I
1.1K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.1K
01:28Pulmonary Tuberculosis II
1.7K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.7K
01:31Pulmonary Tuberculosis III
1.2K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.2K
01:29Therapeutic Drug Monitoring: Affecting Factors
266
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
266